1. Home
  2. OGN vs AAMI Comparison

OGN vs AAMI Comparison

Compare OGN & AAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.11

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

AAMI

Acadian Asset Management Inc.

HOLD

Current Price

$52.38

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
AAMI
Founded
1923
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.0B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
OGN
AAMI
Price
$6.11
$52.38
Analyst Decision
Hold
Hold
Analyst Count
4
3
Target Price
$11.75
$53.00
AVG Volume (30 Days)
3.0M
248.9K
Earning Date
04-30-2026
04-30-2026
Dividend Yield
1.33%
0.79%
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
$6,216,000,000.00
N/A
Revenue This Year
$0.42
$29.60
Revenue Next Year
$1.67
$12.41
P/E Ratio
$8.38
$23.86
Revenue Growth
N/A
N/A
52 Week Low
$6.03
$22.60
52 Week High
$15.36
$57.03

Technical Indicators

Market Signals
Indicator
OGN
AAMI
Relative Strength Index (RSI) 29.92 51.45
Support Level N/A $46.04
Resistance Level $7.87 $56.16
Average True Range (ATR) 0.21 1.61
MACD -0.01 -0.05
Stochastic Oscillator 26.54 55.04

Price Performance

Historical Comparison
OGN
AAMI

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About AAMI Acadian Asset Management Inc.

Acadian Asset Management Inc is a holding company that operates a systematic investment management business through its subsidiary, that offers institutional investors across the globe access to a diversified array of systematic investment strategies designed to meet a range of risk and return objectives.

Share on Social Networks: